INSP
Inspire Medical Systems, Inc.
NYSE · USHealthcareMedical - Devices
$53.27+5.28%
Price as of Jul 20, 2026
INSP financials
Inspire Medical Systems, Inc. financial statements
Annual and quarterly income statement, balance sheet and cash-flow history. On small screens, start with four periods and expand the table when needed.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $912.0M | $802.8M | $624.8M | $407.9M |
| Cost of revenue | $133.2M | $123.0M | $96.6M | $66.1M |
| Gross profit | $778.8M | $679.8M | $528.2M | $341.7M |
| Operating expenses | $727.8M | $643.7M | $568.5M | $389.3M |
| Operating income | $51.0M | $36.1M | -$40.3M | -$47.6M |
| Net income | $145.4M | $53.5M | -$21.2M | -$44.9M |
| EBITDA | $79.8M | $65.0M | -$17.1M | -$40.7M |
| Basic EPS | $4.95 | $1.80 | $-0.72 | $-1.60 |
| Diluted EPS | $4.89 | $1.75 | $-0.72 | $-1.60 |
| Balance sheet | ||||
| Cash & equivalents | $104.8M | $150.2M | $185.5M | $441.6M |
| Total assets | $907.3M | $808.4M | $676.8M | $564.9M |
| Total liabilities | $126.2M | $118.7M | $104.3M | $68.9M |
| Stockholders’ equity | $781.2M | $689.7M | $572.5M | $496.0M |
| Total debt | $32.2M | $31.8M | $24.8M | $16.4M |
| Net debt | -$72.7M | -$118.4M | -$160.7M | -$425.2M |
| Cash flow | ||||
| Operating cash flow | $117.0M | $130.2M | $24.7M | $11.6M |
| Capital expenditure | -$38.5M | -$39.1M | -$23.6M | -$9.1M |
| Free cash flow | $78.5M | $91.1M | $1.0M | $2.5M |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 |
| Share repurchases | -$175.0M | -$75.0M | $0.00 | $0.00 |